Jupiter Bioscience Limited
Add to watch list to get report alerts
BSE Code:
524826
NSE Code:
JUPITER
Business Profile
Business Profile
Jupiter Bioscience (JUPIBIOSC) has business activities focused on peptides, advanced organic chemistry, chiral chemistry and biotechnology. It was established as a private limited company in 1985 and went public in 1995. Earlier known as Jupiter Orga, it got its present name on Feb. 09, 2001.
The ISO 9001:2000 certified company has business operations along the product groups of peptide reagents and protected amino acids, drug intermediates, and specialty and fine chemicals. It manufactures 14 categories of peptide reagents, 6 variety of coupling reagents and over 100 varieties of protected amino acids. Some of the important products in the organic drug intermediate space include Ecpp Alanine, N- Hydroxy and Succinimide among others. In the chiral space, it produces key intermediates used in lisinopril, ramipril and perindropil. Specialty and fine chemicals like methyl resorcinol, 4-chloro resorcinol and methyl resorcinol are produced, which find application in the manufacture of hair dye and as an antimicrobial agent.
The four manufacturing facilities are located at Bidar in Karnataka; Cheriyal, Gaddapotharam and Cherlapally in Andhra Pradesh. The R&D division is located in Cherlapally. The company caters to pharmaceutical companies manufacturing peptide therapeutics and peptide intermediates, biotechnology companies, research-based entities working on new peptide-based therapeutics for cosmetic manufacturers, and chemical manufacturing companies. Apart from manufacturing products, the company provides services such as custom synthesis, process development and scale-up, and contract R&D. It has a strategic alliance with the Clariant group, a global leader in the field of specialty chemicals, for the development of peptides.
Sven Genetech and Jupiter Bioscience Inc. are 100% subsidiaries. Sven Genetech conducts synthesis of peptides including side chain protected amino acids and unnatural amino acids and manufactures nutraceuticals and cosmoceuticals. Jupiter Bioscience Inc, incorporated in USA, caters to the end user market in peptides and peptide components in USA, Europe, Canada and Japan.
The registered office is located at 24 Kolhar, IDA, Bidar-585401, Karnataka.
Financials
Jupiter Bioscience registered a 9.22% growth in net profit to Rs 78.79 million for the quarter ended December 2007 from a profit of Rs 72.14 million for the quarter ended December 2006.
Net sales rose 13.68% to Rs 314.24 million for the quarter ended December 2007 from Rs 276.42 million for the quarter ended December 2006.
Total income rose 13.71% to Rs 315.04 million for the quarter ended December 2007 from Rs 277.05 million for the quarter ended December 2006.
The earnings per share (EPS) of the company stood at Rs 4.34 for the quarter ended December 2007.
Recent Developments
17-FEB-09
The company announced that it has pledged 13,00,000 equity shares as collateral security against loans from nationalized banks. The company clarified that no shares have been pledged by the promoters to secure loan for their own use.
Future Plans
The company aims to increase the R&D team to around 250 scientists.
The company has also planned out an expansion program involving a capital expenditure of Rs 939 million, and it is planning to set up a manufacturing base in the US for catering to the regulated markets and a facility at Hyderabad in order to meeting the needs of non-regulated markets.
The company is also planing to raise upto Rs 950 million by way of foreign currency convertible bonds (FCCBs) to domestic investors including but not limited to institutional buyers, mutual funds, banks, insurance companies and corporate bodies, subject to necessary approvals.